Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.